# A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer

> **NCT02236793** · PHASE3 · COMPLETED · sponsor: **Adocia** · enrollment: 252 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** BioChaperone PDGF-BB
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT02236793
- **Lead sponsor:** Adocia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2017-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236793, "A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02236793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*